company background image
TKNO

Alpha Teknova NasdaqGM:TKNO Stock Report

Last Price

US$4.55

Market Cap

US$128.0m

7D

-7.9%

1Y

-74.0%

Updated

10 Dec, 2022

Data

Company Financials +
TKNO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health3/6
Dividends0/6

TKNO Stock Overview

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally.

Alpha Teknova, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Alpha Teknova
Historical stock prices
Current Share PriceUS$4.55
52 Week HighUS$22.31
52 Week LowUS$3.02
Beta0
1 Month Change21.01%
3 Month Change1.34%
1 Year Change-73.99%
3 Year Changen/a
5 Year Changen/a
Change since IPO-81.80%

Recent News & Updates

Recent updates

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

May 14
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

Shareholder Returns

TKNOUS Life SciencesUS Market
7D-7.9%-2.4%-3.6%
1Y-74.0%-28.2%-20.6%

Return vs Industry: TKNO underperformed the US Life Sciences industry which returned -27.3% over the past year.

Return vs Market: TKNO underperformed the US Market which returned -19.6% over the past year.

Price Volatility

Is TKNO's price volatile compared to industry and market?
TKNO volatility
TKNO Average Weekly Movement13.8%
Life Sciences Industry Average Movement11.7%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: TKNO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: TKNO's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1996240Stephen Gunstreamhttps://www.teknova.com

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

Alpha Teknova, Inc. Fundamentals Summary

How do Alpha Teknova's earnings and revenue compare to its market cap?
TKNO fundamental statistics
Market CapUS$127.99m
Earnings (TTM)-US$37.82m
Revenue (TTM)US$43.64m

2.9x

P/S Ratio

-3.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TKNO income statement (TTM)
RevenueUS$43.64m
Cost of RevenueUS$23.29m
Gross ProfitUS$20.35m
Other ExpensesUS$58.17m
Earnings-US$37.82m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.34
Gross Margin46.62%
Net Profit Margin-86.67%
Debt/Equity Ratio15.1%

How did TKNO perform over the long term?

See historical performance and comparison